Interpreting vaccine efficacy trial results for infection and transmission
View ORCID ProfileMarc Lipsitch, View ORCID ProfileRebecca Kahn
doi: https://doi.org/10.1101/2021.02.25.21252415
Marc Lipsitch
1Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
2Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
Rebecca Kahn
1Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
Article usage
Posted February 28, 2021.
Interpreting vaccine efficacy trial results for infection and transmission
Marc Lipsitch, Rebecca Kahn
medRxiv 2021.02.25.21252415; doi: https://doi.org/10.1101/2021.02.25.21252415
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4351)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)